Paper427730
Tumor thickness as a guide to surgical management of clinical stage I melanoma patients.
Balch CM and 5 others. Cancer, 1979. Cited by 323 papers, by iCite.
Cite this record
ConductScience Library. Tumor thickness as a guide to surgical management of clinical stage I melanoma patients. Papers, record 427730. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/427730
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics7
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Melanoma | Major topic |
| Skin Neoplasms | Major topic |
| Humans | |
| Lymph Node Excision | |
| Neoplasm Metastasis | |
| Neoplasm Recurrence, Local | |
| Neoplasm Staging |
Source PubMed
Cited by37
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 323 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 36811735 | Commentary re PRADO: De-escalation in Melanoma After Neoadjuvant Therapy: When to Cut and When to Cut Back. | Ann Surg Oncol | 2023 | https://conductscience.org/library/papers/36811735 | PubMed |
| 35591818 | Re-excision within a radius of 2 cm in patients with melanoma of the skin - sufficient for local oncological radicalness. | Arch Med Sci | 2022 | https://conductscience.org/library/papers/35591818 | PubMed |
| 30232648 | Sentinel Lymph Node Biopsy and Completion Lymph Node Dissection for Melanoma. | Curr Treat Options Oncol | 2018 | https://conductscience.org/library/papers/30232648 | PubMed |
| 26586498 | Predictors and Survival Impact of False-Negative Sentinel Nodes in Melanoma. | Ann Surg Oncol | 2016 | https://conductscience.org/library/papers/26586498 | PubMed |
| 24521106 | Final trial report of sentinel-node biopsy versus nodal observation in melanoma. | N Engl J Med | 2014 | https://conductscience.org/library/papers/24521106 | PubMed |
| 24340152 | Treatment outcomes of advanced stage malignant melanoma in hand and foot after amputation in Korean patients. | Clin Orthop Surg | 2013 | https://conductscience.org/library/papers/24340152 | PubMed |
| 21748656 | MRI-derived tumor thickness: an important predictor of outcome for T4a-staged tongue carcinoma. | Eur Arch Otorhinolaryngol | 2012 | https://conductscience.org/library/papers/21748656 | PubMed |
| 20689737 | Choroidal pigmented lesions imaged by ultra-wide-field scanning laser ophthalmoscopy with two laser wavelengths (Optomap). | Clin Ophthalmol | 2010 | https://conductscience.org/library/papers/20689737 | PubMed |
| 16633005 | Gender-related differences in outcome for melanoma patients. | Ann Surg | 2006 | https://conductscience.org/library/papers/16633005 | PubMed |
| 11122858 | Surgical management of primary melanoma. | Curr Oncol Rep | 2000 | https://conductscience.org/library/papers/11122858 | PubMed |
| 9462499 | A biopsy is more than a biopsy. | J Gen Intern Med | 1998 | https://conductscience.org/library/papers/9462499 | PubMed |
| 8813254 | Efficacy of an elective regional lymph node dissection of 1 to 4 mm thick melanomas for patients 60 years of age and younger. | Ann Surg | 1996 | https://conductscience.org/library/papers/8813254 | PubMed |
| 8373269 | Efficacy of 2-cm surgical margins for intermediate-thickness melanomas (1 to 4 mm). Results of a multi-institutional randomized surgical trial. | Ann Surg | 1993 | https://conductscience.org/library/papers/8373269 | PubMed |
| 8129491 | Surgical management and prognostic factors in patients with subungual melanoma. | Ann Surg | 1994 | https://conductscience.org/library/papers/8129491 | PubMed |
| 7850524 | Groin dissection in malignant melanoma. | Ann Surg Oncol | 1994 | https://conductscience.org/library/papers/7850524 | PubMed |
| 7352783 | Diagnosis, treatment and prognosis of early melanoma. The importance of depth of microinvasion. | Ann Surg | 1980 | https://conductscience.org/library/papers/7352783 | PubMed |
| 7212800 | A multifactorial analysis of melanoma: III. Prognostic factors in melanoma patients with lymph node metastases (stage II). | Ann Surg | 1981 | https://conductscience.org/library/papers/7212800 | PubMed |
| 7149819 | A comparison of prognostic factors and surgical results in 1,786 patients with localized (stage I) melanoma treated in Alabama, USA, and New South Wales, Australia. | Ann Surg | 1982 | https://conductscience.org/library/papers/7149819 | PubMed |
| 7104199 | Cutaneous malignant melanoma in Scotland. | Br J Cancer | 1982 | https://conductscience.org/library/papers/7104199 | PubMed |
| 7092355 | Factors prognostic for survival in patients with malignant melanoma spread to the regional lymph nodes. | Ann Surg | 1982 | https://conductscience.org/library/papers/7092355 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/427730
GET https://conductscience.org/api/papers/v1/427730/cited_by?page=2